全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

糖尿病合并甲状腺机能亢进症的生存质量及相关因素分析

, PP. 1002-1004

Keywords: 糖尿病,甲状腺功能亢进,生存质量,因素

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的探讨糖尿病合并甲状腺机能亢进症患者的生存质量及其相关影响因素。方法选取2010年2月-2013年2月在新疆维吾尔族自治区人民医院北院接受诊治的125例糖尿病合并甲状腺机能亢进症的患者与100例社区体检人群作为研究对象,采用生存质量量表和相关因素调查表调查,采用回归分析法对相关因素进行分析。结果病例组生存质量得分为(54.6±9.7)分,对照组为(87.6±7.4)分,两组差异有统计学意义(P<0.05);经多因素Logistic回归分析,高T3、T4水平(OR=2.771,95%CI=1.377~8.214)、低TSH水平(OR=2.684,95%CI=1.316~7.024)、年龄(OR=1.108,95%CI=1.006~2.168)、睡眠质量差(OR=1.857,95%CI=1.125~3.871)和抑郁(OR=1.744,95%CI=1.014~4.658)为糖尿病合并甲状腺机能亢进症患者生存质量降低的主要因素;生存质量与睡眠质量呈明显正相关(r=0.865,P<0.05),与抑郁状态、年龄呈显著负相关(抑郁状态r=-0.712、年龄r=-0.519,P均<0.05)。结论糖尿病合并甲状腺机能亢进症患者生存质量明显下降,应采取药物与心理治疗并重的措施,控制病情,心理疏导,提高患者生存质量。

References

[1]  Mercer V,Burt V,Dhatariya KK.New onset type 1 diabetes presenting as ketoacidosis simultaneously presenting with autoimmune hyperthyroidism―a case report[J].J Diabetes Complications,2011,25(3):208-210.
[2]  Arrabal-Polo M A,Jimenez-Pacheco A,Arrabal-Martin M,et al.Hyperthyroidism as a clinical manifestation of a embryonal carcinoma of the testis[J].Acta Clin Belg,2012,67(3):214-216.
[3]  Tack C,Stierle U,Heydrich D,et al.Hyperthyroidism,eosinophilia,and fever in a 64-year-old patient[J].Internist(Berl),2012,53(10):1230-1233.
[4]  Shi L,Shu XO,Li H,et al.Physical activity,smoking,and alcohol consumption in association with Incidence of type 2 Diabetes among middle-aged and elderly Chinese men[J].PLoS One,2013,8(11):e77919.
[5]  Amerion M,Tahajjodi S,Hushmand Z,et al.The effect of maternal thyroid disorders(hypothyroidism and hyperthyroidism)during pregnancy and lactation on skin development in wistar rat newborns[J].Iran J Basic Med Sci,2013,16(5):665-674.
[6]  Diez JJ,Iglesias P.Subclinical hyperthyroidism in patients with type 2 diabetes[J].Endocrine,2012,42(1):157-163.
[7]  Vos XG,Endert E,Tijssen JG,et al.Genotypes in relation to phenotypic appearance and exposure to environmental factors in Graves' hyperthyroidism[J].Eur J Endocrinol,2012,167(6):783-792.
[8]  Mullugeta Y,Chawla R,Kebede T,et al.Dyslipidemia associated with poor glycemic control in type 2 diabetes mellitus and the protective effect of metformin supplementation[J].Indian J Clin Biochem,2012,27(4):363-369.
[9]  Watt T,Cramon P,Bjorner JB,et al.Selenium supplementation for patients with Graves' hyperthyroidism(the GRASS trial):study protocol for a randomized controlled trial[J].Trials,2013,14:119.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133